Via
Medscape:
The U.S. Food and Drug Administration (FDA) has approved first-time generic formulations of glimepiride 1-, 2-, and 4-mg tablets and first-time doses of 3-, 6-, and 8-mg tablets for the management of diabetes mellitus; amlodipine besylate 2.5-, 5-, and 10-mg [base] tablets for the treatment of hypertension and coronary artery disease; and ramipril 1.25-, 2.5-, 5-, and 10-mg capsules for the treatment of hypertension and reduction of cardiovascular risk.
Technorati Tags:
Amaryl,
Norvasc,
Altace
1 comment:
This is great news for the patients and not so great news for Pfizer and Wyeth/Monarch/King pharmaceuticals.
My vets will have an easier time with me getting these agents to them without prostrating myself before the gatekeeper pharmacists.
Post a Comment